Herbas VPB

Print
EN | LT
LT - Antikūnai prieš CTLA-4 ir jų naudojimo būdai
EN - ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/00 (2006.01)
A61P 11/00 (2006.01)
A61P 35/04 (2006.01)
European patent
(11) Number of the document 3551660
(13) Kind of document T
(96) European patent application number 17818406.5
Date of filing the European patent application 2017-12-07
(97) Date of publication of the European application 2019-10-16
(45) Date of publication and mention of the grant of the patent 2023-09-13
(46) Date of publication of the claims translation 2023-12-27
PCT application
(86) Number PCT/US2017/065011
Date 2017-12-07
PCT application publication
(87) Number WO 2018/106862
Date 2018-06-14
Priority applications
(30) Number Date Country code
201662431272 P 2016-12-07 US
Inventors
(72)
VAN DIJK, Marc , NL
MUNDT, Cornelia, Anne , DE
RITTER, Gerd , US
SCHAER, David , US
WOLCHOK, Jedd, David , US
MERGHOUB, Taha , US
WILSON, Nicholas, Stuart , US
SAVITSKY, David, Adam , US
FINDEIS, Mark, Arthur , US
UNDERWOOD, Dennis, John , US
CUILLEROT, Jean-Marie , US
PROSCURSHIM, Igor , US
SHEBANOVA, Olga , US
Grantee
(73) Agenus Inc. , 3 Forbes Road, Lexington, MA 02421, US
Ludwig Institute for Cancer Research Ltd , Stadelhoferstrasse 22, 8001 Zürich, CH
Memorial Sloan Kettering Cancer Center , 1275 York Avenue, New York, NY 10065, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Antikūnai prieš CTLA-4 ir jų naudojimo būdai
  ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF
Last renewal fee
Payment date Validity (years) Amount
2024-12-27 8 277.50 EUR
Next renewal fee
2025-12-07